Keith S. Millingen

654 total citations
17 papers, 541 citations indexed

About

Keith S. Millingen is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Keith S. Millingen has authored 17 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 4 papers in Psychiatry and Mental health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Keith S. Millingen's work include Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Neurological disorders and treatments (3 papers). Keith S. Millingen is often cited by papers focused on Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Neurological disorders and treatments (3 papers). Keith S. Millingen collaborates with scholars based in Australia. Keith S. Millingen's co-authors include Stuart McLean, Gregory M. Peterson, M. G. McCall, Dallas R. English, E G Stewart‐Wynne, S. R. Hammond, J. G. McLeod, Michael S. Roberts, John P. McArdle and E.D. Acheson and has published in prestigious journals such as Brain, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Keith S. Millingen

17 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith S. Millingen Australia 11 211 140 127 94 61 17 541
J. Porcel Spain 9 304 1.4× 107 0.8× 122 1.0× 79 0.8× 19 0.3× 12 458
Shervin Badihian Iran 13 261 1.2× 188 1.3× 81 0.6× 43 0.5× 54 0.9× 48 563
Elisabeth Hazard United States 8 232 1.1× 74 0.5× 333 2.6× 18 0.2× 65 1.1× 10 628
Fraser Moore Canada 11 88 0.4× 130 0.9× 47 0.4× 11 0.1× 18 0.3× 27 434
Steven Schwid United States 8 254 1.2× 221 1.6× 53 0.4× 11 0.1× 28 0.5× 10 424
David Patry Canada 9 168 0.8× 110 0.8× 132 1.0× 11 0.1× 41 0.7× 15 519
Marine Auffret France 13 203 1.0× 103 0.7× 37 0.3× 43 0.5× 22 0.4× 47 531
Layla Thurston United Kingdom 8 32 0.2× 44 0.3× 31 0.2× 36 0.4× 34 0.6× 14 387
Mario O. Melcon Argentina 8 82 0.4× 119 0.8× 79 0.6× 49 0.5× 22 0.4× 20 325
A. Lledó Spain 9 58 0.3× 200 1.4× 66 0.5× 32 0.3× 22 0.4× 15 538

Countries citing papers authored by Keith S. Millingen

Since Specialization
Citations

This map shows the geographic impact of Keith S. Millingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Millingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Millingen more than expected).

Fields of papers citing papers by Keith S. Millingen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Millingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Millingen. The network helps show where Keith S. Millingen may publish in the future.

Co-authorship network of co-authors of Keith S. Millingen

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Millingen. A scholar is included among the top collaborators of Keith S. Millingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Millingen. Keith S. Millingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hammond, S. R., Dallas R. English, J. F. Hallpike, et al.. (1989). The contribution of mortality statistics to the study of multiple sclerosis in Australia.. Journal of Neurology Neurosurgery & Psychiatry. 52(1). 1–7. 48 indexed citations
2.
McArdle, John P. & Keith S. Millingen. (1988). Limbic encephalitis associated with malignant thymoma. Pathology. 20(3). 292–295. 21 indexed citations
3.
Hammond, S. R., J. G. McLeod, Keith S. Millingen, et al.. (1988). THE EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THREE AUSTRALIAN CITIES: PERTH, NEWCASTLE AND HOBART. Brain. 111(1). 1–25. 176 indexed citations
4.
Hammond, S. R., Dallas R. English, Keith S. Millingen, et al.. (1988). The clinical profile of MS in Australia. Neurology. 38(6). 980–980. 30 indexed citations
5.
Peterson, Gregory M., et al.. (1988). Survey of disability that is associated with Parkinson's disease. The Medical Journal of Australia. 149(2). 66–70. 11 indexed citations
6.
Millingen, Keith S., et al.. (1987). Visual evoked responses in diabetes.. PubMed. 24. 153–8. 3 indexed citations
7.
Millingen, Keith S. & Mark Prentice. (1987). Isolated unilateral hypoglossal nerve palsy due to a chondroid chordoma.. PubMed. 23. 213–7. 5 indexed citations
8.
Roberts, Michael S., et al.. (1986). The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders. European Journal of Clinical Pharmacology. 29(6). 703–708. 32 indexed citations
9.
Peterson, Gregory M., Stuart McLean, & Keith S. Millingen. (1985). Food does not affect the bioavailability of baclofen. The Medical Journal of Australia. 142(13). 689–690. 14 indexed citations
10.
Peterson, Gregory M., Stuart McLean, & Keith S. Millingen. (1984). A Randomised Trial of Strategies to Improve Patient Compliance with Anticonvulsant Therapy. Epilepsia. 25(4). 412–417. 85 indexed citations
11.
Peterson, Gregory M., Stuart McLean, & Keith S. Millingen. (1982). Determinants of Patient Compliance with Anticonvulsant Therapy. Epilepsia. 23(6). 607–613. 44 indexed citations
12.
Roberts, Michael S., et al.. (1981). Determination of therapeutic plasma concentrations of tetrabenazine and an active metabolite by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 226(1). 175–182. 15 indexed citations
13.
Millingen, Keith S.. (1976). Epilepsy and driving.. PubMed. 13. 67–72. 6 indexed citations
14.
McCall, Michael, Keith S. Millingen, J. M. Sutherland, et al.. (1968). MULTIPLE SCLEROSIS IN AUSTRALIA. The Medical Journal of Australia. 2(2). 76–77. 1 indexed citations
15.
McCall, M. G., et al.. (1968). Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart.. Journal of Neurology Neurosurgery & Psychiatry. 31(1). 1–9. 44 indexed citations
16.
Millingen, Keith S., et al.. (1966). PERIPHERAL NEUROMYOPATHY FOLLOWING CHLOROQUINE THERAPY. The Medical Journal of Australia. 1(20). 840–841. 5 indexed citations
17.
Millingen, Keith S.. (1963). PRIMARY DISEASES OF MUSCLES. Australian Journal of Physiotherapy. 9(3). 76–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026